Barbara Leyman's Insider Trades & SAST Disclosures
Barbara Leyman's most recent trade in Sutro Biopharma Inc was a trade of 91,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on April 4, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Barbara Leyman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sutro Biopharma Inc | Barbara Leyman | Chief Business Dev. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 91,000 | 91,000 | - | - | Stock Option (Right to Buy) | |
| Sutro Biopharma Inc | Barbara Leyman | Chief Business Dev. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Apr 2025 | 84,500 | 84,500 | - | - | Restricted Stock Units (RSUs) | |
| Sutro Biopharma Inc | Barbara Leyman | Chief Business Dev. Officer | 08 Jul 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy Common Stock) | ||
| Sutro Biopharma Inc | Barbara Leyman | Chief Business Dev. Officer | 08 Jul 2024 | 100,000 | 100,000 | - | - | Restricted Stock Units (RSUs) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges